Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 521 entries
View as:

A Double-blind, Group-comparison P-III Study With Zolpidem MR Using Placebo and Nitrazepam in Insomnia Patients

Phase: N/A Priority: Normal
NCT ID: NCT00374777 Org: User:
Start: 08/31/06 End: 06/30/08 Due: 06/30/09

Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients

Phase: N/A Priority: Normal
NCT ID: NCT00523952 Org: User:
Start: 01/31/04 End: 09/30/05 Due: 09/30/06

A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Liver Transplantation.

Phase: N/A Priority: Normal
NCT ID: NCT00189826 Org: User:
Start: 08/31/04 End: 12/31/06 Due: 12/31/07

A Study to Evaluate the Effect of Oral Mirabegron on the Heart in Healthy Males and Females

Phase: N/A Priority: Normal
NCT ID: NCT01199523 Org: User:
Start: 05/31/10 End: 11/30/10 Due: 11/30/11

A Study to Investigate the Effect of YM150 on the Plasma Concentration of Digoxin in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01514812 Org: User:
Start: 02/28/06 End: 04/30/06 Due: 04/30/07

An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants

Phase: N/A Priority: Normal
NCT ID: NCT02294461 Org: User:
Start: 04/23/14 End: 07/17/24 Due: 07/17/25

Study of FK463 for the Treatment of Invasive Aspergillosis

Phase: N/A Priority: Normal
NCT ID: NCT00036166 Org: User:
Start: 01/29/99 End: 01/31/02 Due: 01/31/03

A Study to Evaluate the Efficacy and Safety of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis Taking Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT02884635 Org: User:
Start: 09/16/16 End: 10/25/17 Due: 10/25/18

Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00064701 Org: User:
Start: 06/30/03 End: 03/31/09 Due: 03/31/10

A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)

Phase: N/A Priority: Normal
NCT ID: NCT00410514 Org: User:
Start: 12/31/06 End: 08/31/08 Due: 08/31/09

Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00658606 Org: User:
Start: 10/31/07 End: 12/31/09 Due: 12/31/10

A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients

Phase: N/A Priority: Normal
NCT ID: NCT00368706 Org: User:
Start: 09/30/06 End: 03/31/08 Due: 03/31/09

A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH

Phase: N/A Priority: Normal
NCT ID: NCT00510406 Org: User:
Start: 01/31/07 End: 09/30/07 Due: 09/30/08

A Study to Evaluate Response of Overactive Bladder Symptom Score (OABSS) to Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01122563 Org: User:
Start: 09/30/09 End: 01/31/11 Due: 01/31/12

Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease

Phase: N/A Priority: Normal
NCT ID: NCT00141960 Org: User:
Start: 09/30/05 End: - Due: -

Celecoxib Japan Observational Study for the Patients With Acute Pain

Phase: N/A Priority: Normal
NCT ID: NCT01876121 Org: User:
Start: 07/31/12 End: 04/30/13 Due: 04/30/14

A Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02140125 Org: User:
Start: 08/31/12 End: 10/31/13 Due: 10/31/14

Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)

Phase: N/A Priority: Normal
NCT ID: NCT01284192 Org: User:
Start: 12/31/10 End: 03/31/16 Due: 03/31/17

A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)

Phase: N/A Priority: Normal
NCT ID: NCT01099345 Org: User:
Start: 07/31/10 End: 05/31/12 Due: 05/31/13

The Survey of Ipragliflozin Treatment in Elderly type2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT02297620 Org: User:
Start: 04/30/14 End: 07/31/15 Due: 07/31/16

Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX

Phase: N/A Priority: Normal
NCT ID: NCT00693524 Org: User:
Start: 11/30/02 End: 03/31/04 Due: 03/31/05

A Study to Assess Drug Interaction of ASP015K and Midazolam

Phase: N/A Priority: Normal
NCT ID: NCT01182077 Org: User:
Start: 06/30/10 End: 07/31/10 Due: 07/31/11

Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT01224041 Org: User:
Start: 08/31/09 End: 06/30/11 Due: 06/30/12

Zolpidem Postmarketing Study in Adolescent Patients With Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00432198 Org: User:
Start: 02/28/07 End: 01/31/10 Due: 01/31/11

To Evaluate if Multiple Doses of Rifampicin Change the Blood Concentration of YM150 (Darexaban)

Phase: N/A Priority: Normal
NCT ID: NCT01406002 Org: User:
Start: 01/31/10 End: 03/31/10 Due: 03/31/11